Navigation Links
Memory Study Enrolling Participants Evaluating Memory Loss Vitamin
Date:2/1/2010

Quincy Bioscience has announced enrollment is underway for a memory loss study evaluating the impact of Prevagen® on cognitive function. Men and women aged 40 years and older who are experiencing memory loss and can travel to Madison, WI area are encouraged to apply at Madison Memory Study.

(Vocus) February 1, 2010 -- Quincy Bioscience is seeking men and women 40 years and older who are experiencing memory loss to enroll in a study that will evaluate the effects of the brain health supplement Prevagen® on cognitive function. The Prevagen Memory Study is a randomized placebo-controlled, double-blind study that will require five (5) visits for cognitive testing during the three (3) month study period. The impact of Prevagen on brain cell protection will be evaluated using computer-based cognitive testing software. The study is sponsored by Quincy Bioscience, the manufacturer of Prevagen®.

Quincy Bioscience is pleased to collaborate with Cogstate Ltd., a leading cognitive testing software company based in Melbourne, Australia. Cogstate’s proprietary computer-based testing software will be utilized to assess the effect of Prevagen on cognitive performance. “We are excited to utilize the testing software from Cogstate for the Madison Memory Study,” says Quincy Bioscience president Mark Underwood. “Cogstate is an industry leader with extensive research validating the use of its software tools for measuring cognitive effects.”

Prevagen® is the first and only product to use the active ingredient apoaequorin, a calcium-binding protein discovered in jellyfish. In university studies, Prevagen® was proven to protect brain cells.* First launched in in September of 2007, tens of thousands of people have taken Prevagen®.

Interested candidates who are able to travel to Madison, WI may visit Madison Memory Study to apply or call (608) 237-3170 for more information about the study.

Quincy Bioscience is a biotechnology company based in Madison, Wisconsin. Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight the aging process. The company's products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms. Quincy Bioscience is developing health applications of the jellyfish protein apoaequorin for dietary supplement and pharmaceutical products. The company’s first product, Prevagenwas launched in the fall of 2007 and is intended to supplement the loss of critical calcium-binding proteins depleted in the normal course of healthy aging.

 
  • These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

###

Read the full story at http://www.prweb.com/releases/2010/1/prweb3540214.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Gladstone scientists uncover potential mechanism of memory loss in Alzheimers disease
2. Scientists synthesize memory in yeast cells
3. Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster
4. Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster
5. Scientists synthesize memory in yeast cells
6. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
7. BioMedical Enterprises, Inc. (BME) Receives FDA Clearance for Spine Use of Its Memory Metal Implants
8. ASU researchers improve memory devices using nanotech
9. Memory Pharmaceuticals to Announce Third Quarter Results on Thursday, November 8, 2007
10. Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia
11. Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Memory Study Enrolling Participants Evaluating Memory Loss Vitamin
(Date:5/23/2016)... and LONDON , May 23, 2016 /PRNewswire/ ... See Frontage Boost Efficiency by 40% - Frontage Implement ... - Frontage Enforce Quality, Compliance and Traceability Within the Bioanalytical lab ... labs in the United States and ... to be deployed across its laboratory facilities. In addition to serving ...
(Date:5/20/2016)... (PRWEB) , ... May 20, 2016 , ... The leading ... of its most experienced veterinary clients have treated over 100 of their own patients ... technology to provide the highest level of care for their patients. , The ...
(Date:5/19/2016)... (PRWEB) , ... May 19, 2016 , ... Anton Paar ... 30,000 square foot office building is complete. The new structure adds a third office ... Anton Paar USA purchased 2.4 acres of land, along with office space ...
(Date:5/19/2016)... DIEGO , May 19, 2016 ... (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced today ... creating the first cord blood based cancer immunotherapeutic ... provisional patent application, Regen described a generation of ... was potentiated by gene silencing.  The product in ...
Breaking Biology Technology:
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
(Date:4/14/2016)... , April 14, 2016 ... Malware Detection, today announced the appointment of Eyal ... new role. Goldwerger,s leadership appointment comes at ... heels of the deployment of its platform at several ... biometric technology, which discerns unique cognitive and physiological factors, ...
(Date:3/31/2016)... 31, 2016  Genomics firm Nabsys has completed a ... Barrett Bready , M.D., who returned to the company ... technical leadership team, including Chief Technology Officer, John ... Steve Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys ...
Breaking Biology News(10 mins):